RT Journal Article
SR Electronic
T1 662 Phase I/II study of ipilimumab plus nivolumab combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A754
OP A754
DO 10.1136/jitc-2023-SITC2023.0662
VO 11
IS Suppl 1
A1 Jain, Rohit
A1 Yang, Yuanquan
A1 Chadha, Juskaran
A1 Chatwal, Monica
A1 Raymond, Sarah
A1 Saunders, Erika
A1 Poehlman, Trey
A1 Fan, Wenyi
A1 Kim, Youngchul
A1 Dhillon, Jasreman
A1 Mortazavi, Amir
A1 Zhang, Jingsong
A1 Sonpavde, Guru P
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A754.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.